SDIC
AMPH icon

South Dakota Investment Council’s Amphastar Pharmaceuticals AMPH Stock Holding History

South Dakota Investment Council’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,360
Closed -$46K – 588
2019
Q4 		$46K Hold
2,360
– – ﹤0.01% 580
2019
Q3 		$47K Buy
+2,360
New +$49.2K ﹤0.01% 612

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

South Dakota Investment Council's AMPH Position: Q1 2020 in Review

South Dakota Investment Council sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2020, closing a stake of 2,360 shares — an estimated $46K sold.

South Dakota Investment Council first reported a position in AMPH in Q3 2019 and held it in 2 quarters. The position peaked at $47K in Q3 2019. 111 funds tracked by Wall St. Rank hold AMPH as of Q1 2020.

  • South Dakota Investment Council reported no remaining Amphastar Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • South Dakota Investment Council sold 2,360 Amphastar Pharmaceuticals shares in Q1 2020, an estimated $46K.
  • South Dakota Investment Council first reported a position in Amphastar Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • South Dakota Investment Council's Amphastar Pharmaceuticals position peaked at $47K in Q3 2019.
  • 111 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2020.

Based on South Dakota Investment Council's 13F filing for Q1 2020, filed 11 May 2020.